Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Larger Is The Vasomotor Menopausal Symptoms (VMS) Treatment Market Expected To Become By 2029 Compared With Its 2025 Level?
The vasomotor menopausal symptoms (vms) treatment market size has experienced robust growth in recent years. It is anticipated to expand from $17.86 billion in 2024 to $19.01 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.5%. The notable expansion observed in the past can be ascribed to elements like hormone replacement therapy (hrt), heightened menopause awareness, progress in pharmaceutical developments, and sustained consumer demand.
The vasomotor menopausal symptoms (VMS) treatment market size is anticipated to undergo significant expansion in the coming years. This market is projected to reach “$24.5 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 6.5%. The expansion throughout the forecast period can be attributed to developments in personalized medicine, non-hormonal innovations, nutritional and dietary interventions, telemedicine, and digital health. Prominent trends for the forecast period include natural and alternative approaches, botanical and herbal remedies, menopause support groups, and cognitive behavioral therapy (CBT).
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13051&type=smp
Which Drivers Are Shaping The Vasomotor Menopausal Symptoms (VMS) Treatment Industry’s Market Share?
A projected rise in the menopause population is anticipated to drive expansion in the vasomotor menopausal symptom’s treatment market. Menopause, a natural biological process, signifies the conclusion of a woman’s reproductive life. This important life phase generally affects women aged between 45 and 55, with an average onset around 51 years old. The increasing count of women experiencing menopause, who require treatment for symptoms like hot flashes and vaginal dryness worldwide, stands as a key driver fueling the growth of vasomotor menopausal symptoms (VMS) treatment. For example, estimates from the Cuyuna Regional Medical Center, a US-based organization, in November 2022, indicated that by 2025, the number of menopausal women will reach 1.1 billion, attributed to increased life expectancy. Furthermore, this menopausal demographic is projected to grow by 1.6% each year until 2060. Consequently, the expanding menopausal population is a significant impetus behind the growth of the vasomotor menopausal symptom’s treatment market.
What Are The Segment Types Shaping The Vasomotor Menopausal Symptoms (VMS) Treatment Market?
The vasomotor menopausal symptoms (vms) treatmentmarket covered in this report is segmented –
1) By Drug Class: Antidepressants; Fluoxetine; Paroxetine; Sertraline; Hormone Therapy; Anticonvulsant; Phenytoin; Phenobarbital; Other Drug Classes
2) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
3) By End-User: Hospitals; Specialty Clinics; Homecare; Other End-Users
Subsegments:
1) By Antidepressants: SSRIs (Selective Serotonin Reuptake Inhibitors); SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors); TCAs (Tricyclic Antidepressants); MAOIs (Monoamine Oxidase Inhibitors); Atypical Antidepressants
2) By Fluoxetine: Depression; Obsessive-Compulsive Disorder (OCD); Panic Disorder; Generalized Anxiety Disorder (GAD); Post-Traumatic Stress Disorder (PTSD); Social Anxiety Disorder; Premenstrual Dysphoric Disorder (PMDD)
3) By Paroxetine: Depression; Obsessive-Compulsive Disorder (OCD); Panic Disorder; Generalized Anxiety Disorder (GAD); Post-Traumatic Stress Disorder (PTSD); Social Anxiety Disorder; Premenstrual Dysphoric Disorder (PMDD)
4) Sertraline: Depression; Obsessive-Compulsive Disorder (OCD); Panic Disorder; Post-Traumatic Stress Disorder (PTSD); Social Anxiety Disorder; Premenstrual Dysphoric Disorder (PMDD)
5) Hormone Therapy: Estrogen Replacement Therapy (ERT); Progestin Therapy; Combined Hormonal Therapy (CHT); Testosterone Replacement Therapy (TRT)
6) Anticonvulsant: Hydantoins; Barbiturates; Benzodiazepines; Valproates; Succinimides; Carboxylic Acid Derivatives
7) Phenytoin: Hydantoins
8) Phenobarbital: Barbiturates
9) Other Drug Classes: Antibiotics; Analgesics; Antidiabetics; Antihypertensives; Anticoagulants; Immunosuppressants; Antipsychotics; Antihistamines
What Long-Term Trends Will Shape The Future Growth Of The Vasomotor Menopausal Symptoms (VMS) Treatment Industry?
Leading companies operating in the vasomotor menopausal symptoms treatment market are actively developing products like Veozah and securing regulatory approvals to introduce new treatment options and address the unmet medical needs of patients. The recent authorizations for novel menopause drugs demonstrate enhanced efficacy and improved safety profiles compared to existing therapies. For instance, in May 2023, Astellas Pharma Inc., a Japan-based pharmaceutical firm, successfully obtained approval for Veozah (fezolinetant) 45 mg once daily from the Food and Drug Administration (FDA), a US-based federal agency. This approval is specifically for the treatment of menopausal vasomotor symptoms (VMS), which vary in intensity from mild to severe. Notably, Veozah stands as the first nonhormonal neurokinin 3 (NK3) receptor antagonist to receive authorization for treating VMS linked to menopause. This hormone-free option operates by blocking a specific pathway within the brain that plays a role in regulating these symptoms. Consequently, it offers an alternative therapeutic choice for women experiencing such symptoms, particularly those who are unable to use or prefer not to utilize hormone therapy. The FDA’s approval of Veozah highlights its significant potential as a new medication for the comprehensive management of menopausal symptoms.
Who Are The Core Companies Influencing The Vasomotor Menopausal Symptoms (VMS) Treatment Market Landscape?
Major companies operating in the vasomotor menopausal symptoms (vms) treatment market are Pfizer Inc., Abbvie Inc., Novartis AG, Ausio Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Kyowa Kirin Co. Ltd., Dr. Reddy’s Laboratories Ltd., Alembic Pharmaceuticals Limited Inc., Apotex Inc., Hikma Pharmaceutical PLC, Endo Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Mundipharma International Ltd., Lupin Limited, Glenmark Pharmaceuticals Ltd., Hisamitsu Pharmaceutical Co. Inc., Zhejiang Huahai Pharmaceutical Co. Ltd., Emcure Pharmaceuticals Limited, Wockhardt Pvt. Ltd., QuatRx Pharmaceuticals Company, Bionovo Inc., Mithra Pharmaceuticals SA, EndoCeutics Inc., Zydus Group, Edgemont Pharmaceuticals LLC, MenoGeniX Inc., Agile Therapeutics Inc.
Download The Full Report For Exclusive Market Findings:
Which Region Shows The Highest Potential For Future Expansion In The Vasomotor Menopausal Symptoms (VMS) Treatment Market?
North America was the largest region in the vasomotor menopausal symptoms (VMS) treatment market in 2024. The regions covered in vasomotor menopausal symptoms (VMS) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Vasomotor Menopausal Symptoms (VMS) Treatment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=13051&type=smp
Browse Through More Reports Similar to the Global Vasomotor Menopausal Symptoms (VMS) Treatment Market 2025, By The Business Research Company
Postmenopausal Osteoporosis Treatment Global Market Report 2025
Menopausal Hot Flashes Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/menopausal-hot-flashes-global-market-report
Pms And Menstrual Health Supplements Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model